Publications
66
Citations
1,244
Est. group size
—
Recurring co-author estimate
Active years
14
Publishing since 2013
Lynn A. Fussner studies ANCA-associated vasculitis, a group of rare autoimmune diseases that cause inflammation of small blood vessels, with particular attention to how it affects the lungs, including alveolar hemorrhage (bleeding into the lung's air sacs) and other pulmonary complications. Their work includes clinical trials and guideline development on treatments such as avacopan, plasma exchange, and glucocorticoids, as well as laboratory research on antibody biomarkers used to diagnose and monitor these conditions. This research is aimed at improving diagnosis, treatment strategies, and clinical outcomes for patients with vasculitis and related lung diseases.
Publication output has grown over the last decade, rising from about 1 per year in 2017-2018 to a peak of 12 in 2025, averaging roughly 6-7 papers per year over the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- ComPLEX controversy: management of alveolar hemorrhage in antineutrophil cytoplasmic antibody-associated vasculitis
American Journal of Respiratory and Critical Care Medicine · 2026
- Treatment With Avacopan in Patients With Respiratory Tract Manifestations of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
ACR Open Rheumatology · 2025
- Pulmonary Manifestations of Systemic Vasculitis
2025
- Clinician Views and Clinic-Pathologic Correlations Concerning the Prevalence and Impact of Granulomas on Diagnosis, Management, and Outcomes of ANCA-Associated Vasculitis: An International Survey
The Journal of Rheumatology · 2025
- Clinician views concerning the prevalence and impact of granulomas on the diagnosis, management, and outcomes of ANCA-associated vasculitis
Lara D. Veeken · 2025
- A CASE OF EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS PRESENTING AS AN IGG4-RELATED DISEASE MIMIC
CHEST Journal · 2025
- Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Results of an International Randomized Controlled Trial (PEXIVAS)
American Journal of Respiratory and Critical Care Medicine · 2024
- Proteinase 3-specific antineutrophil cytoplasmic antibody-associated vasculitis
The Lancet Rheumatology · 2024
- Efficacy and Safety of Avacopan Versus Prednisone Taper in Patients With ANCA-Associated Vasculitis With Lung Involvement: A Post Hoc Analysis of the ADVOCATE Trial
2024
- POS1008 CHARACTERIZATION OF ALPHA-1 ANTITRYPSIN FUNCTION IN ANCA-ASSOCIATED VASCULITIS
Annals of the Rheumatic Diseases · 2024
- Research Bronchoscopies in Critically Ill Research Participants: An Official American Thoracic Society Workshop Report
Annals of the American Thoracic Society · 2023
- Reply: Research Bronchoscopy Standards and the Need for Noninvasive Sampling of the Failing Lungs
Annals of the American Thoracic Society · 2023
- Plasma exchange and glucocorticoid dosing for patients with ANCA-associated vasculitis: a clinical practice guideline
BMJ · 2022
- Activation of a Latent Epitope Causing Differential Binding of Antineutrophil Cytoplasmic Antibodies to Proteinase 3
Arthritis & Rheumatology · 2022
- Cavitary Lung Nodules Caused by HSV Pneumonitis in a Patient with Systemic Lupus Erythematosus
2021
- American Journal of Respiratory and Critical Care Medicine×5
- CHEST Journal×5
- Lara D. Veeken×4
- Journal of the American Society of Nephrology×4
- Arthritis & Rheumatology×2
- Rong Tang
Medicine · The Ohio State University
- Daniel Strunk
Medicine · The Ohio State University
- Sarah P. Cohen
Health Professions · The Ohio State University
- Nozomi Tanaka
Medicine · Indiana University
- Jorge Rojas-Rivera
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile